Head & neck squamous cell carcinoma (HNSCC)

Clinical trials for Head & neck squamous cell carcinoma (HNSCC) explained in plain language.

Never miss a new study

Get alerted when new Head & neck squamous cell carcinoma (HNSCC) trials appear

Sign up with your email to follow new studies for Head & neck squamous cell carcinoma (HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Radioactive antibody targets Hard-to-Treat cancers in early trial

Disease control Recruiting now

This early-phase study tests a new drug called 177LuBetaBart in people with advanced solid tumors that have stopped responding to standard treatments. The drug is a radioactive antibody designed to seek out and destroy cancer cells. The study will enroll about 61 participants and…

Matched conditions: HEAD &AMP; NECK SQUAMOUS CELL CARCINOMA (HNSCC)

Phase 1/2 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Disease control

Last updated Jun 27, 2026 12:01 UTC

Head &amp; neck squamous cell carcinoma (HNSCC)

Get alerted when new Head &amp; neck squamous cell carcinoma (HNSCC) trials appear

Radioactive antibody targets Hard-to-Treat cancers in early trial

Head & neck squamous cell carcinoma (HNSCC)

Get alerted when new Head & neck squamous cell carcinoma (HNSCC) trials appear